Evidence map›Paper›PMID 27924297›Full record

ArticleData in brief2016

Datasets for the validation of the "in vivo" siRNA-silencing of

Miguel Hueso, Laura De Ramon, Estanislao Navarro, Elia Ripoll, Josep M Cruzado, Josep M Grinyo, Joan Torras

Open access · goldAbstract read
In one paragraph

Article in Data in brief, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Miguel HuesoDepartment of Nephrology, Hospital Universitari Bellvitge, and Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Laura De RamonLaboratory of Experimental Nephrology, Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Estanislao NavarroLaboratory of Molecular Oncology, Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Elia RipollLaboratory of Experimental Nephrology, Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Josep M CruzadoDepartment of Nephrology, Hospital Universitari Bellvitge, and Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Josep M GrinyoDepartment of Nephrology, Hospital Universitari Bellvitge, and Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Joan TorrasDepartment of Nephrology, Hospital Universitari Bellvitge, and Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain.
Institut d'Investigació Biomédica de Bellvitge · ESBellvitge University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data presented in this Data in Brief article correspond to the article "in vivo" silencing of

Indexed as

AtherosclerosisCD40Clec/KlrGO analysisMacrophagesmiR-125bNF-kBsiRNA

Identifiers

PMID27924297
PMCPMC5128022
OpenAlexW2549855562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.